Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Apr 12, 2022
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-08+69,424→ 69,424 totalExercise: $3.22Exp: 2032-04-07→ Common Stock (69,424 underlying)
Footnotes (1)
- [F1]The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.